• Molecules directed against tumor cells patented

    Researchers at the ImmunoSensation cluster of excellence at the University of Bonn have managed to do what many scientists dream of: together with researchers from the USA, they have patented new molecules that allow the immune system to be directed against tumor cells.

    Press Release

  • How an Ebola vaccine candidate activates our immune system

    In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. In a further trial, DZIF scientists have now shown in detail how our immune systems react to the tested vaccine "rVSV-ZEBOV" for the first time.

    Press Release

  • "Good to see both sides"

    Oumou Maiga-Ascofaré is currently working as a research fellow at the Bernhard Nocht Institute for Tropical Medicine in Hamburg and at the Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) in Kumasi, Ghana. We asked her about her work in DZIF and her life among different cultures.


  • A list of pathogens sets priorities for antibiotic research

    The WHO has published a list of 12 bacteria groups which are to be given priority for future new antibiotic research and development. DZIF scientists at the University of Tübingen were substantially involved in developing this priority list.

    Press Release

  • New malaria vaccine effective in clinical trial

    Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

    Press Release


  • 18 July 2017 - PRESS RELEASE

    Promising Model for Translational Research

    The German Council of Science and Humanities has given the German Centers for Health Research (DZG) a positive assessment in recognition of the DZG’s outstanding achievements. According to the Council, the DZG are a suitable model to promote translational research in specific areas of disease. In the assessment, the advisory body for the Federal Government and the State Governments (Länder) certified that the six centers play an important role in the German science system and recommended their further development. more ]